John P. Brancaccio, Director at ContraVir Pharmaceuticals, Inc. (CTRV), bought 4,393 shares at $1.49 ($7K) on 2014-03-04, disclosed to the SEC on 2014-03-07.
Open-market purchase of $7k CTRV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2020-12-02 | $11K | — | Filing → |
| CRDF | BUY | 2020-05-18 | $10K | — | Filing → |
| TROV | BUY | 2018-06-13 | $8K | — | Filing → |